About princess®
Threads
(CE 2292)
- Absorbable PDOs for effective skin rejuvenation, reinforcement and lifting
- Safe & easy alternative for light surgical lifting
- Immediate and long lasting effect
- Minimal downtime
princess® Threads
SCREW (CE 2292)
- Coiled shape of the suture ensures higher concentration of PDO material and may lead to a higher collagen production
- Ultra thin wall & sharp needle
BARB II (CE2292)
- Bidirectional cogs hold the skin when the thread is tightened
- Ultra thin wall & sharp needle
BARB II ANCHOR (CE 2292)
- Innovative evolution of the PDO barb II subtype for ultimate elevation of the tissue which lasts longer than the other sutures
- Produced by “cold press & sculpted” molding method – “no excessive heat” preserves the strength
- Bidirectional oriented arrow shaped cogs for ultimate fixation and tissue elevation effect
- L-shape ultra thin wall cannula with special coating with less abrasion
BARB II 4D (CE 2292)
- Bidirection and 4-dimension oriented cogs to maximize fixation
- L-shape ultra thin wall cannula to ensure thicker and stronger suture leading to more collagen production
- Special coating with less abrasion L-shape cannula enables smooth insertion, less pain and minimizes the tissue damage
BARB II PEAKO (CE 2292)
- Optimized suture for contouring nose from bridge to tip without surgery
- Minimally invasive and quick procedure
- Ultra thin wall needle to ensure thicker and stronger suture
- Special coating with less abrasion L-shape cannula enables smooth insertion, less pain and minimizes the tissue damage
What makes princess®
Threads special?
(CE 2292)
-
Clinically proven absorbable polydioxanone (PDO) 1-3
-
Long lasting result (up to 1 year) 4
-
Simple choice of the appropriate suture for different anatomical zones
-
Ergonomic hub for easy and fast application
-
Ultra-Thin Wall needle/cannula enables using thicker and stronger suture
-
Needles with sharp cutting angle to minimize the pain, traumatisation, and downtime
-
Special coating of the needle / cannula enables the smooths application
-
Automated, cutting edge and clean production process
-
CE Mark certified
Effects
- Skin reinforcement and tissue elevation
- Skin rejuvenation
- Tightening and brightening
- Wrinkle smoothing
- Light volumizing
Mechanism of action
Rejuvenation – neo – collagenesis
The maintenance of the aesthetic outcome over months after the reabsorption of the PDO sutures is due to the foreign body reaction (induced by the PDO suture), the enhanced collagen proliferation and the stimulation of fibroblasts at the place of implantation.
Scaffolding – skin reinforcement
When inserted into the skin, the threads act as a ‘scaffold’ that helps to ‘hold’ the skin against the effects of gravity.
Tissue repositioning and elevation
Tissue elevation is the immediate effect, achieved thorough mechanical action by the suture.
References
1. Shimizu, Y. & Terase, K. (2013). Thread lift with absorbable monofilament threads. In Thread lift with absorbable monofilament threads.
2. Costan, V.V., Popescu, E., Sulea, D. & Stratulat, I.S. (2017) A new indication for barbed threads: static reanimation of the paralyzed face. Journal of Oral and Maxillofacial Surgery.
3. Suh, D.H., Jang, H.W., Lee, S.J., Lee, W.S. & Ryu, H.J. (2015) Outcomes of polydioxanone knotless thread lifting for facial rejuvenation. Dermatologic Surgery, 41(6), 720-725.
4. For barbed threads. Ali, Y.H. (2017) 2 years outcome of thread lifting with absorbable barbed pdo threads: Innovative score for objective and subjective assessment. Journal of Cosmetic and Laser Therapy. Journal of Cosmetic and Laser Therapy, Volume 20, 2018 - Issue 1
The medical practitioner confirms having informed the patient of a likely risk associated with the use of the medical device in line with its intended use. For risks and adverse events associated with the use of the product consult the instructions of use.
Distributed by
Croma-Pharma GmbH
Industriezeile 6
2100 Leobendorf
Tel.: +43/ 2262/ 68468 - 0
Fax: +43/ 2262/ 68468 - 165
E-Mail: office@croma.at
Patented and certified by GRAND AESPIO INC.
2F, 41 Hakdong-ro 3-gil, Gangnam-gu, Seoul 06043 Korea
Produced by MEDIFIRST Co.,Ltd.
#1049-16, Charyeonggogae-ro,
Gwandeok-myeon, Dongnam-gu,
Cheonan-si, Chungcheongnam-do,
31223, Republic of Korea
European Representative:
Intermundien-lemon Europe GmbH
Brueckster, 47
D-44787 Bochum, Germany
PTHHP0323